{
    "nct_id": "NCT05003310",
    "official_title": "Multipart Exploratory Study to Evaluate Splenic Nerve Stimulation in Patients With Rheumatoid Arthritis",
    "inclusion_criteria": "* RA of at least six months duration, per 2010 ACR/EULAR criteria\n* Male or female participants, 22-75 years of age\n* Active RA\n* Inadequate Response to at least 2 biologic DMARDs and/or JAK-inhibitors (JAKis) including at least one TNF inhibitor\n* Have an appropriate washout from previously used biological DMARDs or JAKi\n* Receiving current treatment with standard dose(s) of conventional synthetic DMARD(s) or have documented history of failure due to ineffectiveness or intolerance\nHealthy volunteers allowed\nMust have minimum age of 22 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Inability to provide informed consent\n* Significant psychiatric disease or substance abuse\n* History of unilateral or bilateral vagotomy\n* Active or latent tuberculosis\n* Known infection with human immunodeficiency virus (HIV); current acute or chronic hepatitis B or hepatitis C; previous hepatitis B\n* Positive SARS COV 2 PCR screening test for COVID-19 infection (at the point of screening for this study)\n* Currently implanted electrically active medical devices (e.g., cardiac pacemakers, automatic implantable cardioverter-defibrillators)\n* Previous splenectomy",
    "miscellaneous_criteria": ""
}